A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis-Reference-Cited by-同舟云学术

A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis

Published:2007-11 Issue:5 Volume:133 Page:1414-1422
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Plevy Scott,Salzberg Bruce,Van Assche Gert,Regueiro Miguel,Hommes Daniel,Sandborn William,Hanauer Stephen,Targan Stephan,Mayer Lloyd,Mahadevan Uma,Frankel Matthew,Lowder James

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Course and prognosis of ulcerative colitis;Edwards;Gut,1963

2. Intensive intravenous treatment of ulcerative colitis;Jarnerot;Gastroenterology,1985

3. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Jarnerot;Gastroenterology,2005

4. Cyclosporine in severe ulcerative colitis refractory to steroid therapy;Lichtiger;N Engl J Med,1994

5. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis;Ogata;Gut,2006

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel criterion of histologic healing in ulcerative colitis defined by inflammatory cell enumeration in lamina propria mucosa: A multicenter retrospective cohort in China;Chinese Medical Journal;2024-05-13

2. Tolerogenic dendritic cell-mediated regulatory T cell differentiation by Chinese herbal formulation attenuates colitis progression;Journal of Advanced Research;2024-04

3. Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice;Cellular Immunology;2023-03

4. Modulating T Cell Responses by Targeting CD3;Cancers;2023-02-13

5. Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin;Frontiers in Cardiovascular Medicine;2022-01-13